Health care startups that raised Series B in Cambridge, Massachusetts
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| UltraSight | Cambridge | Series B | $24.0M | 2026-09-23 |
| Simnova | Cambridge | Series B | $59.3M | 2026-08-18 |
| Kytopen | Cambridge | Series B | $1.6M | 2026-04-07 |
| Atavistik Bio | Cambridge | Series B | $40.0M | 2026-03-05 |
| Nocion Therapeutics | Cambridge | Series B | $23.0M | 2026-01-07 |
| PineTree Therapeutics | Cambridge | Series B | $47.0M | 2025-10-28 |
| ARTBIO | Cambridge | Series B | $132.0M | 2025-07-29 |
| Epicore Biosystems | Cambridge | Series B | $6.0M | 2025-05-01 |
8 rows of the CSV in 5 of its 18 columns.
- The 75 health care startups in Cambridge, Massachusetts whose last round is Series B have raised $8.2B in total.
- 11 of them closed their most recent round in the last 12 months, $696.4M combined.
- The largest of those rounds is Matchpoint Therapeutics' $150.0M Series B, dated October 2026.
- Alexandria Venture Investments is an investor in 3 of them, more than any other fund.
- Biotech is the most common other sector, with 66 companies (88%).
- 23% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 11 to 50 employees (55% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
11 of 75| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| UltraSight | UltraSight applies machine learning to ultrasound to support more accurate and timely clinical decisions. | Health care | Series B | $24.0M | 2026-09-23 | $39.0M | Yozma Group | 11 to 50 | 2018 |
| Simnova | Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. | Biotech | Series B | $59.3M | 2026-08-18 | $87.2M | Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 | 51 to 100 | 2019 |
| Kytopen | Kytopen develops genome engineering platforms for cell therapy research and manufacturing. | Biotech | Series B | $1.6M | 2026-04-07 | $39.1M | National Science Foundation, MassVentures, Alexandria Venture Investments +1 | 11 to 50 | 2017 |
| Atavistik Bio | Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. | Biotech | Series B | $40.0M | 2026-03-05 | $260.0M | Lux Capital, The Column Group, Nextech Invest | 11 to 50 | 2021 |
| Nocion Therapeutics | Nocion Therapeutics develops pharmaceuticals to treat conditions arising from neurogenic inflammation. | Biotech | Series B | $23.0M | 2026-01-07 | $134.0M | Canaan Partners, F-Prime, OUP (Osage University Partners) +2 | 11 to 50 | 2017 |
| Epicore Biosystems | Epicore Biosystems develops sweat-sensing wearables that deliver personalized health insights. | Hardware | Series B | $6.0M | 2025-05-01 | $41.9M | Alumni Ventures, National Institutes of Health, Joyance Partners +1 | 11 to 50 | 2017 |
| AIRNA | AIRNA develops RNA editing technologies to create medicines for various diseases. | Biotech | Series B | $155.0M | 2025-04-01 | $245.0M | ARCH Venture Partners, Alexandria Venture Investments, Forbion Capital Partners +2 | 51 to 100 | 2021 |
| NextPoint Therapeutics | NextPoint Therapeutics develops therapeutics to treat cancer patients as a clinical-stage biotechnology company. | Biotech | Series B | $42.5M | 2024-02-14 | $122.5M | Invus, Leaps by Bayer, Catalio Capital Management +2 | 51 to 100 | 2020 |
| ROME Therapeutics | ROME Therapeutics develops therapies for cancer and autoimmune diseases by targeting the repeatome. | Biotech | Series B | $72.0M | 2023-09-12 | $199.0M | Andreessen Horowitz, Google Ventures, Alexandria Venture Investments +2 | 11 to 50 | 2020 |
| InsideTracker | InsideTracker provides a platform that analyzes and tracks key biochemical and physiological markers. | Biotech | Series B | $15.0M | 2022-09-06 | $18.2M | OurCrowd, MassVentures, Puget Sound Venture Club +2 | 11 to 50 | 2009 |
| Empatica | Empatica develops affective computing technology and human data analytics. | Artificial intelligence | Series B | $25.9M | 2022-08-02 | $35.6M | Bossa Invest, Endeavor Catalyst, RA Capital Management +2 | 101 to 250 | 2011 |
Table 1. Health care startups that raised Series B in Cambridge, Massachusetts: the 11 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 75.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Simnova | Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. | Biotech | Series B | $59.3M | 2026-08-18 | $87.2M | Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 | 51 to 100 | 2019 |
| 2 | Atavistik Bio | Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. | Biotech | Series B | $40.0M | 2026-03-05 | $260.0M | Lux Capital, The Column Group, Nextech Invest | 11 to 50 | 2021 |
| 3 | UltraSight | UltraSight applies machine learning to ultrasound to support more accurate and timely clinical decisions. | Health care | Series B | $24.0M | 2026-09-23 | $39.0M | Yozma Group | 11 to 50 | 2018 |
| 4 | Nocion Therapeutics | Nocion Therapeutics develops pharmaceuticals to treat conditions arising from neurogenic inflammation. | Biotech | Series B | $23.0M | 2026-01-07 | $134.0M | Canaan Partners, F-Prime, OUP (Osage University Partners) +2 | 11 to 50 | 2017 |
| 5 | Kytopen | Kytopen develops genome engineering platforms for cell therapy research and manufacturing. | Biotech | Series B | $1.6M | 2026-04-07 | $39.1M | National Science Foundation, MassVentures, Alexandria Venture Investments +1 | 11 to 50 | 2017 |
Table 2. Health care startups that raised Series B in Cambridge, Massachusetts: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Alexandria Venture Investments | Venture capital firm | Pasadena, United States | 3 | 4% | 1 | Kytopen |
| 2 | MassVentures | Venture capital firm | Boston, United States | 2 | 3% | 1 | Kytopen |
| 3 | Lux Capital | Venture capital firm | New York, United States | 2 | 3% | 1 | Atavistik Bio |
| 4 | F-Prime | Venture capital firm | Cambridge, United States | 2 | 3% | 1 | Nocion Therapeutics |
| 5 | ARCH Venture Partners | Venture capital firm | Chicago, United States | 2 | 3% | ||
| 6 | RA Capital Management | Startup incubator | Boston, United States | 2 | 3% | ||
| 7 | Andreessen Horowitz | Venture capital firm | Menlo Park, United States | 2 | 3% | ||
| 8 | Casdin Capital | Venture capital firm | New York, United States | 2 | 3% | ||
| 9 | Yozma Group | Government investment office | Tel Aviv, Israel | 1 | 1% | 1 | UltraSight |
| 10 | PagodaTree Partners | Private equity firm | Beijing, China | 1 | 1% | 1 | Simnova |
| 11 | Guochuang Qinzhi | Venture capital firm | 1 | 1% | 1 | Simnova | |
| 12 | Oriza Seed Capital (Oriza Yuandian) | Venture capital firm | Suzhou, China | 1 | 1% | 1 | Simnova |
| 13 | Youshan Capital | Private equity firm | Beijing, China | 1 | 1% | 1 | Simnova |
| 14 | The Engine | Venture capital firm | Cambridge, United States | 1 | 1% | 1 | Kytopen |
| 15 | National Science Foundation | Entrepreneurship program | Alexandria, United States | 1 | 1% | 1 | Kytopen |
Table 3. Health care startups that raised Series B in Cambridge, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
Table 4. Health care startups that raised Series B in Cambridge, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 75 | 100% | $42.5M |
Table 5. Health care startups that raised Series B in Cambridge, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 9% | $150.0M |
| September 2026 | 1 | 9% | $24.0M |
| August 2026 | 1 | 9% | $59.3M |
| June 2026 | 2 | 18% | $161.5M |
| May 2026 | 1 | 9% | $122.0M |
| April 2026 | 1 | 9% | $1.6M |
| March 2026 | 2 | 18% | $117.0M |
| January 2026 | 2 | 18% | $61.0M |
Table 6. Health care startups that raised Series B in Cambridge, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 11 | 15% | $696.4M |
| 2025 | 6 | 8% | $543.0M |
| 2024 | 3 | 4% | $162.5M |
| 2023 | 10 | 13% | $862.0M |
| 2022 | 6 | 8% | $412.9M |
| 2021 | 8 | 11% | $946.0M |
Table 7. Health care startups that raised Series B in Cambridge, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 2 | 3% |
| 2020 to 2022 | 15 | 20% |
| 2015 to 2019 | 30 | 40% |
| 2010 to 2014 | 12 | 16% |
| Before 2010 | 16 | 21% |
Table 8. Health care startups that raised Series B in Cambridge, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 8 | 11% |
| 11 to 50 | 41 | 55% |
| 51 to 100 | 18 | 24% |
| 101 to 250 | 5 | 7% |
| 251 to 500 | 1 | 1% |
| 10,001 or more | 1 | 1% |
Table 9. Health care startups that raised Series B in Cambridge, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series B and its headquarters is in Cambridge, Massachusetts. On 16 November 2026 that is 75 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 11 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 75 rows: 2 have no round amount, 0 no city and 4 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Cambridge, Massachusetts whose last round is Series B are on the list?
- 75, in the file dated 16 November 2026. 11 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 75 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.